CX-024414 for Covid-19: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 22 adverse event reports in the FDA FAERS database where CX-024414 was used for Covid-19.
Most Reported Side Effects for CX-024414
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 117 | 16.9% | 4 | 32 |
| Pyrexia | 89 | 12.8% | 0 | 26 |
| Headache | 87 | 12.6% | 4 | 19 |
| Pain | 81 | 11.7% | 0 | 18 |
| Nausea | 69 | 10.0% | 2 | 10 |
| Chills | 64 | 9.2% | 0 | 18 |
| Pain in extremity | 59 | 8.5% | 0 | 13 |
| Arthralgia | 49 | 7.1% | 0 | 11 |
| Diarrhoea | 45 | 6.5% | 3 | 12 |
| Malaise | 40 | 5.8% | 2 | 9 |
| Asthenia | 39 | 5.6% | 2 | 19 |
| Rash | 38 | 5.5% | 0 | 18 |
| Drug ineffective | 36 | 5.2% | 1 | 12 |
| Dyspnoea | 36 | 5.2% | 3 | 17 |
| Pruritus | 36 | 5.2% | 0 | 8 |
Other Indications for CX-024414
Covid-19 immunisation (385)
Product used for unknown indication (91)
Covid-19 prophylaxis (50)
Immunisation (24)
Prophylaxis (13)
Other Drugs Used for Covid-19
REMDESIVIR (7,196)
HYDROXYCHLOROQUINE (5,280)
BAMLANIVIMAB (4,621)
NIRMATRELVIR\RITONAVIR (4,587)
TOCILIZUMAB (4,186)
DEXAMETHASONE (2,975)
CASIRIVIMAB\IMDEVIMAB (2,943)
SOTROVIMAB (2,732)
AZITHROMYCIN ANHYDROUS (2,510)
METHYLPREDNISOLONE (1,633)